Search Within

Maria Theodoulou-Haber

Formats
  1. Meeting Abstract (33)
  2. Journal Article (31)
  3. Book Section (1)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (63)
  2. Solid Tumor Oncology Division (63)
  3. Breast Medicine Service (60)
  4. Survivorship Research (58)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (48)
  6. Epidemiology and Biostatistics (30)

More Groups

People
  1. Clifford Hudis (58)
  2. Larry Norton (45)
  3. Gabriella D'Andrea-Carlino (25)
  4. Tiffany Traina (23)
  5. Andrew Seidman (22)
  6. Monica Fornier (22)

More People

Years
  1. 2019 (1)
  2. 2016 (1)
  3. 2015 (2)
  4. 2014 (2)
  5. 2013 (3)
  6. 2012 (5)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Breast Cancer Research and Treatment (8)
  3. Cancer Research (6)
  4. Clinical Breast Cancer (5)
  5. Clinical Cancer Research (5)
  6. Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. American Association for Cancer Research (11)
  3. Elsevier Inc. (9)
  4. Springer (8)
  5. Wiley Blackwell (5)
  6. Informa Healthcare (2)

More Publishers

Results (66)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Optimizing chemotherapy dose and schedule by Norton-Simon mathematical modeling
    Journal Article

    Traina, T. A.; Dugan, U.; Higgins, B.; Kolinsky, K.; Theodoulou, M.; Hudis, C. A.; Norton, L.
    Breast Disease (2010)

    Fulltext@MSK | Save
  • Cystoid macular edema secondary to nab-paclitaxel therapy
    Journal Article

    Murphy, C. G.; Walsh, J. B.; Hudis, C. A.; Lake, D.; Theodoulou, M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Safety of a novel capecitabine dosing schedule when combined with lapatinib in patients with HER2-positive metastatic breast cancer refractory to trastuzumab
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Feigin, K.; Patil, S.; Geneus, S.; Modi, S.; Fornier, M.; Lake, D.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Patil, S.; Geneus, S.; Godfrey, L.; Norton, L.; Hudis, C.
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2/neu-positive breast cancer is not feasible due to excessive diarrhea: Updated results
    Meeting Abstract

    Dang, C.; Lin, N.; Moy, B.; Come, S.; Lake, D.; Theodoulou, M.; Troso-Sandoval, T.; Dickler, M.; Gorsky, M.; D'Andrea, G.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Phase I study of nonpegylated liposomal doxorubicin plus trastuzumab in patients with HER2-positive breast cancer
    Journal Article

    Theodoulou, M.; Batist, G.; Campos, S.; Winer, E.; Welles, L.; Hudis, C.
    Clinical Breast Cancer (2009)

    Fulltext@MSK | Save
  • Adjuvant chemotherapy in older women with early-stage breast cancer
    Journal Article

    Muss, H. B.; Berry, D. A.; Cirrincione, C. T.; Theodoulou, M.; Mauer, A. M.; Kornblith, A. B.; Partridge, A. H.; Dressler, L. G.; Cohen, H. J.; Becker, H. P.; more...
    New England Journal of Medicine (2009)

    Fulltext@MSK | Save
  • Malignant lesion segmentation in contrast-enhanced breast MR images based on the marker-controlled watershed
    Journal Article

    Cui, Y.; Tan, Y.; Zhao, B.; Liberman, L.; Parbhu, R.; Kaplan, J.; Theodoulou, M.; Hudis, C.; Schwartz, L. H.
    Medical Physics (2009)

    Fulltext@MSK | Save
  • Phase II trial of patupilone in patients (pts) with breast cancer brain metastases (BCBM) progressing or recurring after whole brain radiation therapy (WBXRT)
    Meeting Abstract

    Conlin, A. K.; D'Andrea, G.; Hudis, C. A.; Robson, M. E.; Drullinsky, P.; Theodoulou, M.; Lis, E.; Kang, T. Y.; Peereboom, D. M.; Seidman, A. D.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Patil, S.; Edwards, C.; Norton, L.; Hudis, C. A.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save